| Financial Year |
March 31 2023 |
| Monetary Funds |
1,743,079,606.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
105,434,476.03 |
| Advances to Suppliers |
78,142,367.20 |
| Other Receivables |
166,879,131.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
11,723,327.09 |
| Dividend Receivable |
-- |
| Inventories |
423,950,236.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,524,268.98 |
| Total Current Assets |
3,228,374,221.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,349,811,422.76 |
| Under-construction Projects |
259,092,320.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
787,106,420.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,622,113.03 |
| Deferred Income Tax Assets |
55,783,127.43 |
| Other Non-Current Assets |
4,589,978.96 |
| Sub-Total of Non-Current Assets |
3,473,647,004.69 |
| Total Assets |
6,702,021,226.60 |
| Short-Term Loans |
1,541,784,397.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
663,577,577.54 |
| Accounts Payable |
343,789,122.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,404,675.95 |
| Taxes Payable |
214,576,552.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
469,637,777.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,701,655.77 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,486,122,691.83 |
| Long-term Loans |
866,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
337,536,674.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,309,679,818.21 |
| Total Liabilities |
4,795,802,510.04 |
| Paid-In Capital(Or Share Stock) |
819,514,395.00 |
| Capital Surplus |
1,336,320,056.95 |
| Surplus Reserve |
362,965,147.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-632,262,702.26 |
| Minority Stockholder's Interest |
10,234,138.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,895,984,578.27 |
| Owner's Equity（Stockholder's Equity） |
1,906,218,716.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,702,021,226.60 |
